| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/23/2006 | US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/23/2006 | US20060040921 Process and intermediates for the preparation of olanzapine |
| 02/23/2006 | US20060040920 Crystal forms of olanzapine and processes for their preparation |
| 02/23/2006 | CA2577261A1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | CA2576421A1 Inhibitors of hcv replication |
| 02/23/2006 | CA2575188A1 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
| 02/23/2006 | CA2575056A1 Selected fused heterocyclics and uses thereof |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627069A2 Methods for the isolation and purification of ansamitocins |
| 02/22/2006 | CN1738615A Diaminotriazoles useful as inhibitors of protein kinases |
| 02/21/2006 | CA2309340C Pyrimidine derivatives for labeled binding partners |
| 02/21/2006 | CA2065986C 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments |
| 02/16/2006 | WO2006016167A2 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 02/16/2006 | WO2005062748A3 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 02/16/2006 | WO2004015119A3 Methods for the isolation and purification of ansamitocins |
| 02/16/2006 | US20060035953 Cyclizing an N-carboxymethyl-N-alkanoyl-3-formyl-2-thiophenylamine and optionally amidating the product |
| 02/16/2006 | US20060035908 Thienopyrimidines useful as Aurora kinase inhibitors |
| 02/16/2006 | US20060035887 Process for preparing olanzapine |
| 02/16/2006 | US20060035883 Novel serotonin receptor ligands and their uses thereof |
| 02/16/2006 | US20060035878 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 02/16/2006 | US20060035325 Regulated apoptosis |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | CA2575582A1 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 02/15/2006 | EP1625117A1 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indictor in the detection of microorganisms with peptidase activity |
| 02/15/2006 | CN1735620A Pure levofloxacin hemihydrate and processes for preparation thereof |
| 02/15/2006 | CN1735601A Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 02/15/2006 | CN1735402A Polymer composition including large ring alkatriene compound |
| 02/15/2006 | CN1733769A Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/14/2006 | CA2347298C Organic initiators and their use in the polymerization of unsaturated monomers |
| 02/09/2006 | CA2575340A1 Macrocyclic beta-secretase inhibitors |
| 02/09/2006 | CA2575100A1 Heterocyclic compounds |
| 02/08/2006 | EP1622914A2 New piperidinylamino-thieno 2,3-d pyrimidine compounds |
| 02/08/2006 | EP1622685A1 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors |
| 02/08/2006 | EP0911328B1 Substituted aminocycloalkylpyrrolidine derivatives |
| 02/08/2006 | CN1732175A Method for producing pyridoxine or an acid addition salt thereof |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995153 tachykinin receptor antagonist, in particular, an NK1 receptor antagonist; prophylactic or therapeutic agent against tachykinin receptor-related pathological conditions, including increased urinary frequency, incontinence, vomiting, inflammation |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 02/02/2006 | WO2005047245A3 Fluorescence assays with improved blocking groups |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025356 28-epirapalogs |
| 02/02/2006 | CA2574307A1 Rifamycin derivatives for treating microbial infections |
| 02/02/2006 | CA2574301A1 (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 02/02/2006 | CA2573538A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 02/01/2006 | EP1620440A1 Synthesis of substituted heterocyclic compounds |
| 02/01/2006 | CN1729196A Process for producing optically active sulfoxide |
| 02/01/2006 | CN1729188A Synthesis of heteroaryl acetamides |
| 02/01/2006 | CN1239631C Acid pigment dispersants and pigment preparations |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/26/2006 | WO2006008091A2 Oxidative degradation products of atorvastatin calcium |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060019959 Novel quinoxalinone derivatives |
| 01/26/2006 | US20060019941 Prophylaxis or prevention of aberrations in a signal transduction pathway mediated by a cKit kinase by administering 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents |
| 01/26/2006 | US20060019939 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 01/26/2006 | US20060019906 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 01/26/2006 | CA2573969A1 Oxidative degradation products of atorvastatin calcium |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators |
| 01/25/2006 | EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 01/25/2006 | CN1726212A Pre-organized tricyclic integrase inhibitor compounds |
| 01/25/2006 | CN1726207A Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/25/2006 | CN1724537A Method of synthesizing methanesulfonic acid parzhushaxing intermedinte |
| 01/25/2006 | CN1238348C Oxazin(thio)one compounds used as fungicides |
| 01/24/2006 | US6989445 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/19/2006 | WO2006007491A1 Mitotic kinesin inhibitors |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006290A1 PROCESS FOR PRODUCING 1-OXACEPHALOSPORIN-7α-METHOXY-3-CHLOROMETHYL DERIVATIVE |
| 01/19/2006 | WO2005105805A9 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/19/2006 | US20060014956 Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014947 Levofloxicin prepared by reduction of an entantiomorph of 2,3,4 trihalo,N-(1-alkoxycarbonylethyl-)aniline by a metal borohydride in an aprotic solvent and alcohol; reacting the product with a 2,2-dialkoxycarbonyl-ethyl halide; cyclization using a base and phase transfer agents; optical purity;efficiency |
| 01/19/2006 | US20060014731 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 01/19/2006 | CA2571807A1 Mitotic kinesin inhibitors |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 01/18/2006 | EP1207161B1 Novel isoindole derivatives |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/17/2006 | US6987117 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| 01/17/2006 | US6987116 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 01/17/2006 | CA2152284C Condensed benzo(d)isoxazole derivatives and their use as psychoactive agents |
| 01/12/2006 | WO2006004658A2 Furanopyrimidines |
| 01/12/2006 | WO2006002928A1 Compounds having affinity for the dopamine d3 receptor and uses thereof in medicine |
| 01/12/2006 | WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/12/2006 | WO2005077958A8 Resolution of racemates of methyl alpha-5-[4,5,6,7-tetrahydro[3,2-c]thienopyridyl]-(2-chlorophenyl)acetate |
| 01/12/2006 | WO2005051958A3 Particle-forming compositions containing fused pyrrolocarbazoles |
| 01/12/2006 | US20060009508 5-alkyl-2-thia-5-azabicyclo[2.2.1]heptan-3-ones or salts thereof which are useful as synthetic intermediates |
| 01/12/2006 | US20060009463 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 01/12/2006 | CA2571857A1 Furanopyrimidines |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1474404A4 Method for extracting a macrolide from biomatter |
| 01/11/2006 | CN1718579A Asparagic acid levo oxyfluorsaxin and its preparation method |